mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.04 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.05 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.05 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.05 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |